PRJNA870904
Comparison of the translatome of WT or eIF4E depleted HT1080 cells in normal and RSL3 treatment
We applied RiboLace, a novel method for the isolation of active ribosomes by means of an antibody-free and tag-free pull-down approach, to compare the active ribosome profiles of WT or eIF4E depleted HT1080 cells in normal and RSL3 treatment.